River Global Investors LLP Has $1.42 Million Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

River Global Investors LLP decreased its stake in Stericycle, Inc. (NASDAQ:SRCL) by 0.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 28,619 shares of the business services provider’s stock after selling 245 shares during the quarter. River Global Investors LLP’s holdings in Stericycle were worth $1,419,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Clarkston Capital Partners LLC lifted its holdings in shares of Stericycle by 0.8% during the 3rd quarter. Clarkston Capital Partners LLC now owns 6,524,331 shares of the business services provider’s stock valued at $291,703,000 after buying an additional 52,087 shares during the last quarter. Black Creek Investment Management Inc. grew its position in Stericycle by 1.1% in the third quarter. Black Creek Investment Management Inc. now owns 5,493,782 shares of the business services provider’s stock worth $245,627,000 after acquiring an additional 62,400 shares in the last quarter. Ariel Investments LLC increased its stake in shares of Stericycle by 5.7% during the 3rd quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after purchasing an additional 233,612 shares during the last quarter. Impax Asset Management Group plc increased its stake in shares of Stericycle by 4.9% during the 4th quarter. Impax Asset Management Group plc now owns 3,139,032 shares of the business services provider’s stock worth $154,396,000 after purchasing an additional 147,452 shares during the last quarter. Finally, Earnest Partners LLC raised its holdings in shares of Stericycle by 6.6% during the 3rd quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock valued at $86,793,000 after purchasing an additional 120,852 shares in the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on SRCL. Robert W. Baird lowered their target price on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, April 26th. Wells Fargo & Company raised their price objective on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $69.00 target price on shares of Stericycle in a research report on Thursday, March 7th. Stifel Nicolaus lifted their price target on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. Finally, Truist Financial decreased their price objective on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a report on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $59.40.

Stericycle Price Performance

Shares of Stericycle stock traded up $1.38 during midday trading on Friday, hitting $46.18. 423,599 shares of the company were exchanged, compared to its average volume of 506,754. The firm has a 50 day simple moving average of $50.91 and a 200-day simple moving average of $48.28. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. The firm has a market cap of $4.29 billion, a P/E ratio of -209.91, a PEG ratio of 2.49 and a beta of 1.12. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $57.06.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. The company had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business’s revenue was down 2.8% on a year-over-year basis. During the same period last year, the business earned $0.49 earnings per share. Research analysts forecast that Stericycle, Inc. will post 2.32 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.